Question 1

Does ProShare Advisors own TXG stock?

Accepted Answer

Yes. As of its Q3 2026 13F, ProShare Advisors holds 18,880 shares of TXG (10x Genomics), worth $1.7M.

Question 2

How many shares of TXG does ProShare Advisors own?

Accepted Answer

As of its Q3 2026 13F, ProShare Advisors holds 18,880 shares of TXG (10x Genomics).

Question 3

What is ProShare Advisors' TXG position worth?

Accepted Answer

As of its Q3 2026 13F, ProShare Advisors' TXG position is worth $1.7M.

Question 4

Is ProShare Advisors buying or selling TXG?

Accepted Answer

In Q3 2026, ProShare Advisors reduced its TXG position by 572 shares (-2.9%).

Question 5

When did ProShare Advisors first buy TXG?

Accepted Answer

ProShare Advisors first reported TXG in its Q1 2021 13F and has listed it in 10 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Decreased	18,880	-2.9%	$1.7M	0.0%	$90.36	0
2026-Q2	Decreased	19,452	-9.8%	$745,789	0.0%	$38.34	0
2026-Q1	Decreased	21,565	-14.8%	$457,825	0.0%	$21.23	0
2025-Q4	Increased	25,325	+13.0%	$413,051	0.0%	$16.31	27
2025-Q3	Decreased	22,417	-13.1%	$262,055	0.0%	$11.69	0
2025-Q2	New	25,803	—	$298,799	0.0%	$11.58	32